Nattosyn

product on market Capsule Douglas Laboratories Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 33% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Nattokinase and hesperidin methyl chalcone are researched for their roles in supporting fibrinolytic activity and vascular health. Pomegranate extract provides antioxidant properties, though evidence for these specific combined effects remains limited. These ingredients are generally well-tolerated with a high safety profile.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Nattosyn
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Vegetarian Capsule(s)
Serving Size
60
Servings
Other Combinations
Product Type
33%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Hesperidin Methyl Chalcone
100 mg
50 mg
Market median: 100.0mg (70 products)
Market median: 250.0mg (182 products) 10 studies (A:0, B:2)

Other Ingredients

Microcrystalline Cellulose Hydroxypropyl Methylcellulose Silica Vegetable Stearate
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested Usage: As a dietary supplement, adults take 1-2 capsule, 1-2 times daily or as directed by your health professional.

Warnings & Precautions

Warning: Not to be taken by pregnant or lactating women. If you have any health condition or are taking any medication, consult your health professional before use.

Keep out of the reach of children.

Use only if safety seal is intact.

Contains: Soy

Formulation Notes

Gluten-free, Non-GMO

Circulatory health

Additional Information

Store in a cool, dry place.

Scan to learn about our manufacturing excellence Contents may not fill package in order to accommodate required labeling. Please rely on stated quantity.

Metadata

Product Details

UPC / SKU3 10539 02240 5
DSLD Entry Date2020-10-23
Product TypeOther Combinations
FormCapsule
DSLD ID237131
Data Updated2026-04-11
Research

Research Evidence

4
Research Sources
45
Avg Quality
2
Rct
1
Other
1
Systematic Review
B Nattokinase Supplementation and Cardiovascular Risk Factors: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Systematic Review Reviews in cardiovascular medicine 2023 PubMed DOI
C Effects of nattokinase on blood pressure: a randomized, controlled trial
Rct Hypertension research : official journal of the Japanese Society of Hypertension 2008 PubMed DOI
C A single-dose of oral nattokinase potentiates thrombolysis and anti-coagulation profiles
Rct Scientific reports 2015 PubMed DOI
D [A clinical study on the effect of nattokinase on carotid artery atherosclerosis and hyperlipidaemia]
Other Zhonghua yi xue za zhi 2017 PubMed DOI
View all evidence for Nattokinase →
Compare

Similar Products

View all Nattokinase products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.